Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals
- PMID: 30581269
- PMCID: PMC6295835
- DOI: 10.3748/wjg.v24.i46.5203
Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals
Abstract
Liver transplantation for critically ill cirrhotic patients with acute deterioration of liver function associated with extrahepatic organ failures is controversial. While transplantation has been shown to be beneficial on an individual basis, the potentially poorer post-transplant outcome of these patients taken as a group can be held as an argument against allocating livers to them. Although this issue concerns only a minority of liver transplants, it calls into question the very heart of the allocation paradigms in place. Indeed, most allocation algorithms have been centered on prioritizing the sickest patients by using the model for end-stage liver disease score. This has led to allocating increasing numbers of livers to increasingly critically ill patients without setting objective or consensual limits on how sick patients can be when they receive an organ. Today, finding robust criteria to deem certain cirrhotic patients too sick to be transplanted seems urgent in order to ensure the fairness of our organ allocation protocols. This review starts by fleshing out the argument that finding such criteria is essential. It examines five types of difficulties that have hindered the progress of recent literature on this issue and identifies various strategies that could be followed to move forward on this topic, taking into account the recent discussion on acute on chronic liver failure. We move on to review the literature along four axes that could guide clinicians in their decision-making process regarding transplantation of critically ill cirrhotic patients.
Keywords: Acute on chronic liver failure; Cirrhosis; Critical; Ethical; Intensive; Intubation; Liver transplantation; Organ failure; Sepsis.
Conflict of interest statement
Conflict-of-interest statement: None of the authors declare conflicts of interest
Figures
References
-
- Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–96. - PubMed
-
- Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg. 2007;142:1079–1085. - PubMed
-
- Dellon ES, Galanko JA, Medapalli RK, Russo MW. Impact of dialysis and older age on survival after liver transplantation. Am J Transplant. 2006;6:2183–2190. - PubMed
-
- Weismüller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, Paul A, Scherer MN, Schmidt HH, Schlitt HJ, et al. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the ‘sickest first’-concept. Transpl Int. 2011;24:91–99. - PubMed
-
- Berry PA, Thomson SJ, Rahman TM, Ala A. Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis. Aliment Pharmacol Ther. 2013;37:174–182. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources